Related Experiment Video
Updated: Jan 4, 2026

19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
19.0K
Distinguishing Four HCV Genotypes by Loop Mediated Isothermal Amplification Assay
Clinical Laboratory
|November 12, 2019
Summary
A new loop-mediated isothermal amplification (LAMP) method effectively detects and distinguishes four hepatitis C virus (HCV) subtypes prevalent in China. This sensitive and specific assay aids in clinical diagnosis and treatment strategies for HCV infection.
Area of Science:
- * Molecular Biology
- * Virology
- * Diagnostic Assays
Background:
- * Hepatitis C virus (HCV) genotyping is crucial for effective clinical management and treatment decisions.
- * Prevalence of specific HCV subtypes (1b, 2a, 3, and 6a) in China necessitates targeted diagnostic tools.
Purpose of the Study:
- * To develop and validate a loop-mediated isothermal amplification (LAMP) method for the simultaneous detection and differentiation of four major HCV subtypes in China.
- * To assess the specificity and sensitivity of the developed LAMP assay compared to established methods.
Main Methods:
- * Primer sets for HCV subtypes 1b, 2a, 3, and 6a were designed for LAMP assay.
- * LAMP reactions were optimized at 65°C for 60 minutes.
- * Assay performance was evaluated using clinical sera, synthesized nucleic acids, and cross-reactivity testing with other hepatitis viruses (HBV, HIV, HAV).
- * Limit of detection (LOD) was determined by serial dilution and compared with Real-time PCR.
Main Results:
- * The established LAMP assay successfully detected and differentiated HCV subtypes 1b, 2a, 3, and 6a.
- * Specificities for HCV subtypes 1b, 2a, 3, and 6a were 100%, 85%, 90%, and 100%, respectively.
- * The limit of detection (LOD) ranged from 1.0 x 10³ IU/mL for HCV-2a to 1.5 x 10³ IU/mL for HCV-1b, 3, and 6a.
Conclusions:
- * The developed LAMP method is a feasible, sensitive, and specific tool for distinguishing between common HCV subtypes in China.
- * This assay holds potential for improving HCV diagnosis and guiding patient treatment strategies.

